|
|
|
Insider
Information: |
Homcy Charles J |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
1,546,413 |
|
Indirect Shares
|
188,122 |
|
|
Direct
Value |
$42,508,427 |
|
|
Indirect Value
|
$3,452,400 |
|
|
Total
Shares |
1,734,535 |
|
|
Total
Value |
$45,960,827 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Millennium Pharmaceuticals Inc |
MLNM |
Director |
2008-05-09 |
0 |
2004-02-17 |
1,119 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2011-05-11 |
62,751 |
2007-01-03 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2019-01-02 |
112,471 |
2019-01-02 |
185,403 |
Premium* |
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2017-10-27 |
67,728 |
2017-10-27 |
1,600 |
Premium* |
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-02-16 |
1,230,085 |
2019-07-01 |
0 |
Premium* |
|
Pliant Therapeutics, Inc. |
PLRX |
Director |
2020-06-02 |
73,378 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BBIO |
Bridgebio Pharma, Inc. |
|
|
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,231,594 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
|
|
2024-02-16 |
4 |
D |
$37.21 |
$56,150 |
D/D |
(1,509) |
1,230,085 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,361,426 |
1,361,426 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-01-14 |
4 |
AS |
$35.00 |
$350,000 |
D/D |
(10,000) |
1,362,291 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-01-14 |
4 |
OE |
$17.00 |
$170,000 |
D/D |
10,000 |
1,372,291 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-02-10 |
4 |
AS |
$36.00 |
$720,000 |
D/D |
(20,000) |
1,342,291 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-04-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
1,302,291 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-25 |
4 |
AS |
$36.68 |
$2,985,455 |
D/D |
(81,057) |
1,221,967 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-29 |
4 |
AS |
$37.50 |
$682,500 |
D/D |
(18,200) |
1,203,767 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-30 |
4 |
OE |
$17.00 |
$170,000 |
D/D |
10,000 |
1,213,767 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-30 |
4 |
AS |
$38.00 |
$380,000 |
D/D |
(10,000) |
1,203,767 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-10-16 |
4 |
OE |
$17.00 |
$174,352 |
D/D |
10,256 |
1,214,023 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-10-16 |
4 |
AS |
$41.00 |
$420,496 |
D/D |
(10,256) |
1,203,767 |
0 |
% |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2003-09-04 |
4 |
S |
$14.92 |
$76,424 |
D/D |
(5,121) |
106,487 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2003-09-05 |
4 |
OE |
$4.59 |
$137,700 |
D/D |
30,000 |
136,487 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2003-09-05 |
4 |
S |
$15.30 |
$380,676 |
D/D |
(24,879) |
111,608 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2004-02-02 |
4 |
OE |
$4.59 |
$247,534 |
D/D |
50,000 |
161,608 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2004-02-02 |
4 |
S |
$18.10 |
$904,800 |
D/D |
(50,000) |
111,608 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2004-02-10 |
4 |
OE |
$4.60 |
$1,058 |
D/D |
230 |
111,838 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2004-02-17 |
4 |
OE |
$5.54 |
$223,013 |
D/D |
40,255 |
152,093 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2004-02-17 |
4 |
S |
$19.17 |
$771,672 |
D/D |
(40,255) |
111,838 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2004-03-08 |
4 |
D |
$18.27 |
$20,499 |
D/D |
(1,122) |
111,838 |
|
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2006-11-21 |
4 |
S |
$11.41 |
$228,580 |
D/D |
(20,000) |
111,838 |
0 |
- |
|
MLNM |
Millennium Pharmaceutical... |
Director |
|
2006-11-21 |
4 |
OE |
$6.34 |
$126,800 |
D/D |
20,000 |
131,838 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2007-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
108 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|